UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	August 15, 2023

Accession Number:	0001193125-23-210776
Submission Type:	POS AM
CIK: 0001821323 Company Name: Sigilon Therapeutics, Inc. File Number: 333-264296